Sitagliptin Modulates Functional and Phenotypic Properties of Human Neutrophils Under Normal- and High-Glucose Conditions In Vitro. [PDF]
Mališ V +8 more
europepmc +1 more source
Low dose of sitagliptin: effectively prevent liver aGVHD and accelerate neutrophil engraftment. [PDF]
Liu M, Zhong Z, Wang H.
europepmc +1 more source
Glycaemic and Cardiometabolic Outcomes of Empagliflozin Versus Sitagliptin Added to Metformin in T2DM: Insights From a Systematic Review and Meta-Analysis. [PDF]
Ashraf S +10 more
europepmc +1 more source
Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS). [PDF]
Xiong W, Li Y, Huang J, He G, Sun J.
europepmc +1 more source
Five-year follow-up of incretin-based therapy in a patient with KCNJ11-related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction. [PDF]
Ohkuma T +4 more
europepmc +1 more source
Limited Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Appetite and Body Weight: Evidence From Clinical and Rodent Studies. [PDF]
Lee J +8 more
europepmc +1 more source
Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial. [PDF]
Lim RP +9 more
europepmc +1 more source
DPP-4 Inhibitors in Female Cancers: Opportunities for Drug Repurposing. [PDF]
Muddather HF, Schelz Z, Zupkó I.
europepmc +1 more source
Metformin and Sitagliptin Impact the Brain Kynurenine Pathway: Region-Specific Modulation of Neuroactive Metabolites in Non-Diabetic Male Rats. [PDF]
Bednarz K +3 more
europepmc +1 more source

